Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India.
That's according to a report in The Economic Times on Tuesday, citing a company spokesperson.
While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement,
The company is exploring how to accelerate the availability of its vaccine in India, the newspaper added.


Fire breaks out at Oil Sector Complex in Kuwait
Four dead after passenger vehicle plunges off road in northern India
Arab Parliament, GCC condemn attack on UAE embassy in Damascus
Trump gives Iran 48 hours to make deal, hunt continues for missing US pilot
US arrests relatives of Iran's Qassem Soleimani